Use of rifaximin and of pharmaceutical compositions containing it in the treatment of the diarrhoea from cryptosporidiosis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 23, 1999
Grant Date -
N/A
app pub date -
Jan 26, 1998
filing date -
Feb 14, 1997
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The use of therapeutically effective amounts of rifaxmin and of pharmaceutical compositions containing it in the treatment of the diarrhoeal symptomatology in case of cryptosporidiosis in patients suffering from severe forms of immunodepression, for instance patients suffering from AIDS or malignant neoplasias, or subjected to transplantations or treated with chemotherapeutic or immunosuppressive agents is the object of the present invention.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully